This byline is co-authored by Ramji Vasudevan, Head of Life Sciences at Altimetrik, and Adam Caplan, President of Digital Business and AI at Altimetrik. Together, they bring deep expertise in helping pharmaceutical enterprises bridge the gap between innovation pilots and scalable adoption of digital and AI solutions.
In this article published in PME (Pharmaceutical Market Europe) they explain how pharmaceutical firms are moving beyond cautious pilots to enterprise-scale adoption of digital engineering and AI solutions. From AI-driven supply chain optimization and intelligent manufacturing to patient onboarding, compliance bots, and conversational analytics, Ramji and Adam outline how practical AI applications are already improving efficiency, reducing costs, and enhancing patient outcomes. They also highlight the rise of multi-agent orchestration and data-connected AI systems as the next frontier for regulated pharma environments.
Launches PharmaOS as the Center’s first offering, taking clients from concept to validation in a week
Vikas Krishan, Chief Digital Business Officer and Head of UK and EMEA at Altimetrik, explains in The Fintech Times why rising AI usage does not guarantee better business outcomes. As organisations adopt agentic AI, he calls for clearer links between cost, value and ownership. He also argues that changes to EU AI Act timelines should […]
Altimetrik CEO Raj Sundaresan is featured in Newsweek, bringing our approach to AI, talent development and workplace culture to a global audience. Recognised among America’s Greatest Workplaces in Tech 2026, Altimetrik puts these commitments into practice through learning, experimentation and meaningful career opportunities. With more than 80% of our workforce having completed foundational AI training, […]
